Singapore markets open in 3 hours 30 minutes

IQVIA Holdings Inc. (IQV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
186.20+5.06 (+2.79%)
At close: 04:03PM EDT
186.20 0.00 (0.00%)
After hours: 04:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close181.14
Open184.24
Bid185.96 x 900
Ask186.74 x 800
Day's range181.09 - 187.96
52-week range180.16 - 285.61
Volume1,019,623
Avg. volume942,353
Market cap34.728B
Beta (5Y monthly)1.35
PE ratio (TTM)31.94
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022

    RESEARCH TRIANGLE PARK, N.C., October 03, 2022--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2022 financial results before the market opens on Wednesday, October 26, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

  • Business Wire

    IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation

    RESEARCH TRIANGLE PARK, N.C., September 28, 2022--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its Decentralized Clinical Trial (DCT) program has received GDPR compliance validation from TRUSTArc. This marks the first instance of a DCT service receiving this European data privacy validation.

  • Business Wire

    New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials

    RESEARCH TRIANGLE PARK, N.C., September 07, 2022--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced new evidence that decentralized clinical trials (DCT) deliver measurable benefits for patients, sites and sponsors.